Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Site visit: Building PGE-nickel-copper riches at the Stillwater West project, Montana

Initially published in Resource Opportunities. Subscribe now: use coupon code CEO to save US$100 on regular subscription prices of US$299 for 1 year or $449 for 2 years. ResourceOpportunities.com/subscription-information/ Assays are pending for holes drilled th...
James Kwantes | December 4, 2019 |

Boston Scientific Reports 13% Q3 Sales Growth and Raises Yearly Estimates

This morning shares of Boston Scientific traded 6% higher after the firm reported a 13.1% increase in revenue for Q3/19. The firm also raised its revenue guidance for both Q4/19 and FY/19. Early this morning medical device maker Boston Scientific Corp. (BSX:NYSE) an...
Streetwise Reports | October 24, 2019 |

Electromed Earnings Spark a 25% Increase in Its Share Price

Shares of SmartVest maker Electromed traded 25% higher today after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. Develo...
Streetwise Reports | November 14, 2019 |

Tech Data Shareholders Thankful for Apollo Global's Raised Buyout Offer

Shares of Tech Data Corp. traded 12% higher today after Tiger Midco LLC, an affiliate of Apollo Global, raised its takeover bid for the company to $145 per share, an 11.54% increase over its prior $130 per share offer earlier this month. Global wholesale distributor o...
Streetwise Reports | December 2, 2019 |

Renewable Energy MLP Announces Acquisition, Dividend Increase

The specifics of both moves are presented in an iA Securities report. In a Jan. 13 research note, analyst Jeremy Rosenfield reported that iA Securities raised its target price on Brookfield Renewable Energy Partners L.P. (BEP.UN:TSX) to CA$47 per share from CA$44. T...
Streetwise Reports | January 17, 2020 |

Karyopharm Trades Up 60% on Positive Phase 3 Multiple Myeloma Results

Karyopharm Therapeutics shares set a new 52-week high price after the company reported that its Phase 3 BOSTON trial of XPOVIO® achieved significant increases in progression-free survival in patients suffering with multiple myeloma. Oncology-focused...
Streetwise Reports | March 3, 2020 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

Mersana Therapeutics Trades 60% Higher on Positive Phase 1 Ovarian Cancer Trial Data

Shares of Mersana Therapeutics reached a new 52-week high price after the company reported positive interim data from the expanded portion of its Phase 1 study of XMT-1536 for treatment of ovarian cancer. Clinical-stage biopharmaceutical company Mersana Therapeuti...
Streetwise Reports | May 28, 2020 |

Deciphera's Shares Open 115% Higher on Phase 3 Ripretinib Results

Deciphera Pharmaceuticals announced positive top-line results from the INVICTUS pivotal phase 3 clinical study of ripretinib in patients with advanced gastrointestinal stromal tumors. Early this morning, clinical-stage biopharmaceutical company Deciphera Pharmaceutic...
Streetwise Reports | August 14, 2019 |

New Deal 'Step In Right Direction Toward Turnaround for Energy Firm'

The new agreement and its potential impact on Point Loma Resources are discussed in a Mackie Research Capital Corp. report. In an April 21 research note, Mackie Research Capital Corp. analyst Bill Newman wrote that the transaction outlined in Point Loma Res...
Streetwise Reports | April 28, 2020 |
1 2 3 4 5 6 7 8 9 10 ...